vimseltinib
deciphera
['vimseltinib', 'deciphera']
$dcph new article : deciphera pharmaceuticals, inc. presents updated phase 1/2 data for vimseltinib in tgct at the european society for medical oncology (esmo) congress 2022 get all the latest $dcph related news here : 
We’ll make staying up-to-date on top of your investments easy for you. Create a free account and get real-time financial news updates for your portfolio!